 |
Date & Place |
|
|
|
Organizers |
|
|
|
Focusing Areas |
|
|
|
Program |
|
|
|
Proceedings |
|
|
|
1AAAW
2001.
6.1-2
Tokyo |
|
|
|
Y.Hayashi
V.Young |
|
|
|
Review of AA science status review of, Function, Untoward consequences of abnormal intake, Evaluation of desirable & undesirable intake |
|
|
|
|
ILSI(イルシー).
2001;68:87-92.
(in Japanese) |
|
|
|
2AAAW
2002.
10.31-11.1
Hawaii |
|
|
|
L.Cynober
Y.Hayashi
M.Kadowaki
V.Young |
|
|
|
Background and framework of risk assessment, pharmacokinetics, function and metabolism, What can be learned from Genome science |
|
|
|
|
|
3AAAW
2003.
10.23-24
Nice,
France |
|
|
|
L.Cynober
Y.Hayashi
M.Kadowaki
V.Young |
|
|
|
Factors affecting amino acid adequacy and their regulatory impact: Physiological factors, variation among populations, scientific issues associated with risk assessment |
|
|
|
|
|
4AAAW
2005.
10.28-29
Kobe, Japan |
|
|
|
D.Baker
D.Bier
L.Cynober
Y.Hayashi
M.Kadowaki
A.Renwick |
|
|
|
Animal models and biomarkers for assessing adequate dietary intake of BCAA: Diff. b/w nutr. vs toxicol. effects, Biomarkers for nutr. effects and toxicity, How similar are animals to humans |
|
|
|
|
|
5AAAW
2005.
10.24-25
LosAngeles |
|
|
|
D.Baker
D.Bier
L.Cynober
Y.Hayashi
M.Kadowaki
A.Renwick |
|
|
|
Anim.models&biomarkrs fr assessing adeq.diet.intake of sulfur-containing AAs(SAA): Metabol&function, Adeq. range for SAA & biomarkers for their excess, Effects of SAA excess & suggested UL |
|
|
|
|
|
6AAAW
2006.
11.6-7
Budapest,
Hungary |
|
|
|
D.Baker
D.Bier
L.Cynober
Y.Hayashi
M.Kadowaki
S.Morris
A.Renwick |
|
|
|
Animal models and biomarkers for assessing adequate and safe intake of Lys, Arg and related amino acids |
|
|
|
|
|
7AAAW
2007.
11.2-3
Tokyo |
|
|
|
D.Baker
D.Bier
L.Cynober
Y.Hayashi
M.Kadowaki
S.Morris
A.Renwick |
|
|
|
I. Consideration for setting upper intake levels for nutrients (co-organized with ILSI)
II. Animal models and biomarkers for assessing adequate and safe intake of Gln & Pro. |
|
|
|
|
